All posts by imreal

CREO, Inc. Announces the Appointment of Sam Osman to the Board of Advisors


News Image

CREO, Inc. announced today the appointment of Sam Osman to the company’s Board of Advisors, effective May 1, 2020. Osman’s appointment was announced by Susan Acker-Walsh, co-founder and Managing Partner of CREO, an innovative management consulting and advisory firm based in Durham, NC.

Over the last two decades, Osman has led or invested in a number of businesses within life sciences. Most recently he served as CEO of Cenduit, an eClinical technology firm from 2016 to 2020 with a successful sale to IQVIA in December 2019. Previously with Quintiles, the world’s largest Contract Research Organization, he oversaw a number of businesses focused on patient centricity, data collection and safety monitoring including building from scratch the industry’s first and largest connected devices, sensors, and wearables hub. He also held business and corporate development roles successfully closing in excess of $1bn in deals with pharma and biotech customers as well as several M&A and licensing transactions.

“We are excited to welcome Sam to our Board of Advisors. Sam brings 15 years of leadership in key areas such as healthcare economics, pharmaceuticals and life sciences, and information technology and services, that are critical to our future operations and strategy,” said Susan Acker-Walsh, CREO’s CEO. “Sam will bring energy to our board and strengthen CREO’s commitment to enhancing mission-critical solutions to better serve our clients, employees, and stakeholders.”

Osman says he is excited to join the board of a growing management consulting firm and use his experience to accelerate positive change. “Having experienced firsthand the value that CREO brings to its clients combined with the deep domain experience that Mike and Susan bring, I’m delighted to join the board and help continue the exponential momentum that the team has built over the past few years.”

Osman holds a BSc in Economics and Biochemistry from the University of Tampa, an MSc in Economics from the London School of Economics, and an MBA with distinction from Carnegie Mellon University. He was named to the PharmaVoice Top 100 Leaders in Healthcare and the Triangle Business Journal 40 under 40 in 2019, and the Top 25 Entrepreneurs in the State of Pennsylvania.

About CREO, Inc.: CREO is an innovative management consulting firm that shapes growth companies into healthy successful organizations. We provide holistic support for organizations through our expertise in growth management and digital transformation. Our approach creates alignment around vision and strategy with the goal of driving execution and results. To learn more, please visit us at http://www.creoinc.net.

Share article on social media or email:

Boulder Smile Design Expands Their Team With Addition of New Pediatric Dentist, Dr. Jennifer Rubin, D.M.D.


Dr. Jennifer Rubin, D.M.D.

“I absolutely love treating children, and I care for each one like my own.”

Boulder Smile Design is proud to welcome Dr. Jennifer Rubin, D.M.D. to its practice. Dr. Rubin is a board-certified pediatric dentist, allowing the practice to expand services and provide comprehensive care for its growing number of patients.

“Dr. Rubin is an exceptional addition to our team,” said Jesse Friedman, D.M.D., owner of Boulder Smile Design. “She is an extremely skilled dentist and has a huge heart, both of which make her an amazing pediatric and special needs dentist.”

Since she was a little girl, Dr. Rubin always knew she wanted to be a dentist for kids. Dr. Rubin attended Boston University, where she received a Bachelor of Science in Psychology, a Master’s in Biomedical Sciences, and finally her dental degree from the Boston University Henry M. Goldman School of Dental Medicine. She graduated with magna cum laude honors. She followed that with a hospital-based General Practice Residency at New York Presbyterian-Weill Cornell Hospital in New York City and then completed her residency in pediatric dentistry at Mount Sinai Hospital in New York City as well. In addition to her range of dental service expertise, Dr. Rubin is an active member in the Boulder dental community, volunteering with a number of local organizations and regularly visiting local schools and daycare centers to educate children. She is a member of the American Dental Association, the Colorado Dental Association, and the Metro Denver Dental Society. She is board certified from the American Board of Pediatric Dentistry and also maintains an active membership with the American Academy of Pediatric Dentistry. She takes continuing education classes every chance she gets and stays up-to-date on the latest in pediatric and special needs care.

“I wanted to join Boulder Smile Design because I knew that the levels of care matched my own rigorous standards,” said Dr. Rubin. “They have always provided exceptional dentistry in Boulder. I absolutely love taking care of children, and I treat for each one like my own.”

Boulder Smile Design has provided high-end dental care for families in the area for nearly 50 years, with just over 10 in its current location. All dentists in the office work to understand individual patient dental needs and use state-of-the-art materials and equipment to achieve these goals. Services are comprehensive and range from ongoing preventative care to emergency dentistry services. Patients of all ages count on the dental cleaning and checkup services to prevent cavities, avoid gum disease, and boost overall health. The office uses absolutely no amalgam or mercury fillings; resin composite (white fillings) and sealant services provide further proactive and restorative dental care to ensure the ongoing health of each tooth and patient. Advanced restorative and prosthodontic services, such as crowns, bridges, porcelain veneers, and dental implants are also available to provide natural-looking improvements for stained, chipped, decayed, damaged, or broken teeth. The dentists stay up-to-date with a variety of continuing education, including sleep medicine, sleep apnea, and sleep-disordered breathing; craniofacial growth, cosmetic dentistry, laser technology, orthodontics, and complex rehabilitative care. The dentists employ a range of digital technology, including 3-D oral scanners, ultra-low-radiation digital x-rays, and the newest and most advanced equipment for diagnosing and treating disease.

The dentists at Boulder Smile Design take their role and engagement in the community seriously. Each dentist has donated considerable pro bono dental work for a range of non-profit organizations including Give Kids a Smile, the Dental Lifeline Network, and the Colorado Mission of Mercy. The professionals in the practice understand the important role dental health and esthetics play in both overall wellness and confidence in life.

“We have a responsibility for our patients and our city,” Dr. Friedman said. “We view every day as an opportunity to give our very best to patients and the community overall. Every single person should have the opportunity to receive phenomenal care in a comfortable, relaxing, stress-free environment.”

Boulder Smile Design is open Mondays, Tuesdays, and Thursdays from 7-5; Wednesdays from 7-3; and select Fridays and Saturdays. Call to ask about your dental insurance. It is located at 3000 Center Green Drive, Suite 215, Boulder, CO 80301. Learn more about Boulder Smile Design at http://www.bouldergeneraldentist.com or call for an appointment (303) 442-6142.

Share article on social media or email:

Enzymedica’s New Black Elderberry Plus Probiotics and Zinc Promotes Respiratory Tract Health and Provides Immune Support Using the Highest Quality Elderberry in the World


Immunity boost, supplement for immunity, Elderberry, vitamins, new dietary supplements, zinc, probiotics

Made from the Haschberg-variety, the finest elderberries in the world, each serving is equal to 80 berries and also contains 11 mg of Zinc and 5 billion CFU of Bacillus subtilis DE111® Probiotic.

Enzymedica®, a Florida-based company that produces high quality natural digestive products, announced today the launch of its newest immunity support supplement – Black Elderberry Plus Probiotics and Zinc On-The-Go Immune Packs. * The convenient, delicious quick-melt is sugar free and can be placed on the tongue or sprinkled on a favorite food. Made from the Haschberg-variety, the finest elderberries in the world, each serving is equal to 80 berries and also contains 11 mg of Zinc and 5 billion CFU of Bacillus subtilis DE111® Probiotic.

Zinc has been shown in clinical studies to help the body make protein and DNA, while the primary mechanism of action for its immune support impact is its influence on the RNA replication of invaders. * In addition, the Probiotic DE111 is a clinically studied strain of Bacillus subtilis that delivers digestive and immune health benefits. *

However, the star of Enzymedica’s new immune health supplement is the ElderCraft® European Black Elderberry Extract from Austria. Naturally rich in anthocyanins, polysaccharides and berry micronutrients, the ElderCraft® extract has been clinically studied for its natural effects on the immune system. * It is made using an exclusive technology that treats fruits gently without using any harsh solvents. The solvent-free, extraction process allows the phytonutrient integrity of the berry to be maintained. As a result, ElderCraft® supports immune health in the following ways:

●    Provides support for overall immune health. *

●    Supportive supplement for sinus and upper respiratory tract health. *

●    Immune defense during times of stress. *

●    Throat and chest supplement. *

●    Helps soothe a scratchy throat. *

The new Black Elderberry Plus Probiotics and Zinc On-The-Go Immune Packs are $19.99 for 15 powder packs and can be purchased at https://enzymedica.com/products/black-elderberry-plus-probiotics-zinc?variant=32085269184561. It contains 425mg of ElderCraft European Black Elderberry in each serving and is free from gluten, milk, casein, soy, egg, and artificial colors or flavors. It can be paired with Enzymedica’s Enzyme Defense for added support. *

About Enzymedica

Florida-based Enzymedica is a leading natural digestive health company since 1998 and sells to over 30,000 stores worldwide and online. Its top-selling enzyme brand is No. 1 in America. The company has received more than 50 industry awards including multiple Better Nutrition Magazine’s People’s Choice Awards, many Best of Supplements Awards and numerous VITY and Nexty Awards. Visit https://enzymedica.com/ for more information.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease.

Media Contact:

Ria Romano, Partner

RPR Public Relations, Inc.

Tel. 786-290-6413-

Share article on social media or email:

Verinovum Announces Chronic Care Management/COVID-19 Data Assessment for Payers


News Image

As we continue to face the COVID-19 crisis to varying degrees, payers need to proactively intervene with those who have co-related chronic diseases, including those with asthma, CHF, COPD, and diabetes to manage future medical costs and ensure their long-term health and well-being.

Healthcare data curation and enrichment company Verinovum announced today it is offering free data assessments to help payers analyze the quality and completeness of their patient clinical data necessary to identify and provide care for specific chronic disease states that render their members vulnerable to COVID-19.

“In the aftermath of the initial COVID-19 pandemic, payers are now asking how they can more accurately identify their most at-risk populations. And many have found it’s only by integrating, cleansing and enriching clinical data that they can finally connect the dots and serve their most vulnerable chronically ill members,” says Verinovum CEO Mark McCurry. “As we continue to face the COVID-19 crisis to varying degrees, payers need to proactively intervene with those who have co-related chronic diseases, including those with asthma, CHF, COPD, and diabetes to manage future medical costs and ensure their long-term health and well-being.”

Verinovum’s COVID-19 related chronic condition data assessment helps payers assess the quality of their clinical data for these specific conditions and pinpoint exactly which data elements are needed for each member cohort. The assessment involves two phases: within 60 days of receiving raw clinical data, Verinovum delivers a high-level report identifying gaps in overall data completeness. Then, 30 days thereafter, Verinovum highlights areas where significant data enrichment improvements are possible for specific chronic disease use cases such as asthma or diabetes, including medications, diagnosis, procedures, lab results, vital signs, and more.

Due to the urgency and gravity of the pandemic, the assessment is being made available to payers at no cost as part of Verinovum’s ongoing commitment to helping healthcare organizations combat COVID-19.

As an example of how Verinovum helps improve data quality, in a recent engagement with a major national health plan, only 14% of the raw clinical data had the proper structure and requisite data elements to support advanced clinical and analytical use cases. After Verinovum curated and enriched the data, more than 89% was usable, directly impacting patient outcomes and dramatically improving data integrity for use with downstream applications.

“I’ve seen firsthand the lack of clean, complete clinical outcomes data that payers need to impact care at the population level,” says Kelley Smith, RN, MPH. “Finally, there’s a methodology available to extract, clean and enrich these critical data elements. It’s more important than ever, with the severity of COVID-19 being correlated with certain co-morbidities, that payers have the tools necessary to identify chronic conditions and pre-empt adverse events whenever possible.”    

About Verinovum

Verinovum is a market leader in clinical data curation and enrichment, enabling payers, providers, clinically integrated networks, and accountable care organizations to improve operating performance and quality with actionable information. By delivering clean, complete, and accurate data, Verinovum supports healthcare organizations in their efforts to access the right information, in the right format, at the right time, so it may be tailored and curated to fulfill specific use cases and achieve mission-critical clinical and business goals. Discover more at Verinovum.com.

Share article on social media or email:

The Washington Post Names Actualize Consulting a 2020 Top Workplace


Actualize Consulting’s culture supports work/life balance.

I am most proud that this award is based on surveys taken by our team. It is truly a pleasure to work with such a talented and dedicated group. Founding Principal, Chad Wekelo

Actualize Consulting has been named one of The Washington Post’s 2020 Top Workplaces in the Washington, D.C. area. “I believe that our foundation of our people first and a keen focus on gratitude enables us to thrive. Communication, productivity, teamwork, employee engagement, and motivation all flourish when you infuse your corporate culture and life with gratitude,” said Chief Operating Officer Kerry Wekelo.

Top Workplace selection is based solely on employee feedback gathered through an anonymous third-party survey administered by research partner Energage, LLC, which measured several aspects of workplace culture, including alignment, execution, and connection. Actualize Consulting’s culture is a testament to their Culture Infusion program, which is the impetus to Kerry’s second business book, Gratitude Infusion: Workplace Strategies for a Thriving Organizational Culture.

Actualize Consulting puts people first while honoring their mission to be an industry leader in the management and automation of financial functions and corporate financial events. Principal Matt Seu said, “It is always a pleasure to share our unique workplace culture with others! Actualize consultants are dedicated to our clients’ success and put in the extra effort and enthusiasm needed to do their jobs well. What sets us apart is the commitment we made to incorporate the principles of goodwill, positivity, and gratitude. This is a win worth celebrating!”

“Now in its seventh year, The Post’s Top Workplaces list continues to highlight the companies that are leaders in the Washington-area in terms of employee engagement and satisfaction,” said Washington Post Top Workplaces editor Dion Haynes. “We had a record number of employees participate in the survey this year, making it clear that these organizations have made cultivating an atmosphere of support and respect a priority.”

The full list along with additional content will run in print in a special Top Workplaces magazine on October 14 and will be available on The Post’s site. The Washington Post will also host an awards ceremony in October to recognize the 200 top-ranked companies.

Actualize Consulting is a professional financial services firm specializing in business process engineering and technology solutions for clients in financial, insurance, government, and fortune 1,000 companies. As a boutique consulting firm, we specialize in complex operations of financial data and transformation in the areas of Capital Markets, Collateral, Mortgage and Fixed Income, and Treasury Operations.

Share article on social media or email:

Cablefax Call for Entries for The Diversity List; Deadline: July 10


“We’re so excited to honor the incredible people that help businesses thrive and drive diversity and inclusion excellence,” said Cablefax Publisher Michael Grebb. “The evidence is indisputable: A diverse workforce drives good business decisions and generates the best new ideas and innovations.”

Every year, Cablefax recognizes the top multi-ethnic executives based on their influence and power within the industry—as well as their commitment to ensuring that other executives of color receive the same opportunities to grow and flourish. Help Cablefax celebrate the women and men who are shaping the industry and opening doors for people of color across all areas of business. As always, it’s free to nominate candidates for the Diversity List.

New for 2020, Cablefax is expanding the recognition for Diversity & Inclusion excellence by adding 12 individual & organization award recognitions, including LGBTQ+ executive of the year.

Individual Categories include:

  • Diverse Executive of the Year
  • LGTBQ+ Executive of the Year
  • D&I Champion
  • D&I Mentor of the Year
  • The Trailblazers
  • Thrivers Under 30

Organization Categories include:

  • Advertising Campaign
  • Community Outreach
  • D&I Mentoring Program
  • Diversity in Business
  • Public Affairs Campaign
  • Recruiting Initiatives

Category descriptions and more details available at http://www.cablefaxdiversity.com

The Diversity List honorees will be announced in the September issue of Cablefax: The Magazine. Previous magazine digital issues available at http://www.cablefaxmag.com

Share article on social media or email:

Mesa Science Associates and Bryn Pharma Publish Final of Three Pre-Clinical Studies of a New Approach to Treating Anaphylaxis


Mesa Science Associates Inc. (MSA) and Bryn Pharma LLC published the findings from the final of three (3) pre-clinical studies conducted in beagle dogs. These studies establish that epinephrine is readily absorbed when administered intranasally and has advantages over an intramuscular injection of epinephrine. The pre-clinical study was managed by MSA and was conducted at MRI Global Laboratories in Kansas City, MO. The study was funded by Bryn Pharma LLC of Raleigh, NC and was published in Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, entitled Effects of Intranasal Epinephrine on Cerebrospinal Fluid Epinephrine Pharmacokinetics, Nasal Mucosa, Plasma Epinephrine Pharmacokinetics, and Cardiovascular Changes.

This study compared the absorption of epinephrine given intranasally and by intramuscular injection. Doses examined were 4 and 5 mg intranasally, and 0.3 mg intramuscularly. The maximum plasma concentrations of epinephrine post-administration were similar in both intranasal and intramuscular delivery. However, intranasal epinephrine showed a higher plasma epinephrine level within one-minute post-drug administration. Furthermore, the intranasal dosing did not damage the nasal mucosa nor did it penetrate into the central nervous system.

Ultimately, the study supports the safe and convenient use of intranasal delivery of epinephrine to treat severe allergy and anaphylaxis.

Ken Dretchen, PhD, MSA Chief Science Officer and lead author stated, “The overall study results show a viable alternate route of administration for epinephrine, via the nostril, reducing the anxieties that come along with an auto-injector and the associated hypodermic needle injection. Intranasal administration of epinephrine could lead to increased usage versus an auto-injector, with less hesitation for use in patients with severe allergies.”

The planned clinical studies will further investigate intranasal epinephrine pharmacokinetic and pharmacodynamic effects. Michael Mesa of MSA stated, “It has been greatly satisfying for MSA to be partnered with Bryn Pharma on this important work to expand the use and availability of epinephrine to those who are burdened by its current mode of administration.”

He also noted that “during the conduct of these studies no animal was injured and all study animals were adopted into forever homes.”

In addition to the pre-clinical studies, MSA continues to provide support for Bryn Pharma nasal product development activities including device activities, identification of a contract fill and finish source, and coordination with the fill and finish source for Chemistry, Manufacturing and Controls activities. MSA also utilizes its extensive list of pharmaceutical experts to provide advice on a variety of manufacturing, clinical, quality, technical and scientific issues.

Mesa Science Associates is a pharmaceutical product development company located inside the Frederick Innovative Technology Center Inc. (FITCI) in Frederick, MD. Kathie Callahan Brady, President and CEO of FITCI added, “we are very excited for MSA and the publication of the pre-clinical trials. We wish them the best of luck with their continued work with this project over the summer.”

MSA’s mission is to provide technical and scientific expertise to researchers from all aspects of the drug, drug delivery and product development community, including researchers from government, academia, in addition to private entities.

For more information on Mesa Science Associates visit http://www.mesascience.com/.

Share article on social media or email:

MRC|X and Stratum International Merge to Create MRC Global


MRC|X, a Memphis-based regulatory and quality systems consulting firm, has merged with Stratum International, a life sciences consulting firm and wholly-owned subsidiary of Denver-based Pinnacle Healthcare Consulting, to create MRC Global.

The new company will be led by a team of life sciences and medical device industry veterans who have partnered to provide comprehensive solutions in the areas of regulatory, quality, clinical, fair market value and transactional support to medical device, pharmaceutical, biologic and tissue companies within the life sciences community.

MRC Global’s leadership team’s depth of life sciences industry experience includes spinal, orthopedic, trauma and neurological implants and bone void fillers; biologic, tissue and human cellular-based products; medical mobile applications; capital equipment with software (cardiac, infusion imaging, navigation, light and laser-based devices); personal protection equipment (masks, shields, gowns); and dental devices.

The new company will offer a broad range of professional services including global regulatory assessment, planning and strategy; pre-submission, 510(k), Emergency Use Authorization (EUA), Investigational Device Exemption (IDE) Pre-Market Approval (PMA) and de novo preparation and submission to FDA; European technical file and design dossier preparation; FDA, Notified Body, and ISO 13485 audit preparation and participation; Tissues auditing, licensing and registration; and supplier and internal audits, valuation services (company or device), royalty arrangements, co-branding fair market value, and innovative processes to document Key Opinion Leader (KOL) status and payment rate sheet development.

“This partnership with Christine Scifert, Dawn Norman and the exceptional team at MRC|X is a fantastic opportunity to elevate our services to clients around the world,” said David White, Partner Pinnacle Healthcare Consulting and CEO of Stratum International. “Their expertise, industry reputation and professional integrity is a strong complement to the work Stratum and Pinnacle have developed over the years.”

“We are excited about the next step in our continued growth and look forward to being part of a company with expanding services,” said Christine Scifert, Partner with MRC|X. “The partnership and leadership of Pinnacle’s highly successful management team, combined with the depth of our medical device and tissue experience, will lead to more comprehensive support for our clients and continued success.”

About Pinnacle Healthcare Consulting

With over 70 experienced professionals, six consulting divisions and five affiliated companies, Pinnacle Healthcare Consulting provides a broad range of strategic, financial and operational services to hospitals, health systems, physician groups, law firms and other health care organizations to improve clinical and business performance and long-term sustainability. Learn more at AskMRCGlobal.com and AskPHC.com.

Share article on social media or email:

RestoraPet Expands Manufacturing Capabilities; Offers Consumer Products Supporting Entire Family Wellness


RestoraPet will start producing tens of thousands of bottles of premium-quality hand sanitizer under the company’s newest sub-brand, Rejuvien

RestoraPet will start producing tens of thousands of bottles of premium-quality hand sanitizer under the company’s newest sub-brand, Rejuvien

As the world continues to constantly change, it became increasingly important to us to keep up with the needs of our customers and their entire families – both pets and humans.

RestoraPet, the world’s most effective pet supplement, announced today that it has added premium-quality Rejuvien hand sanitizer product to its portfolio, available immediately for purchase by pet parents and the general public on the company’s website at https://restorapet.com/.

Bottles of hand sanitizer will be available in 2, 4 or 16 oz. bottles, signaling the company’s pivot to manufacturing wellness products for humans and pets alike. Currently, RestoraPet customers receive a free bottle of Rejuvien sanitizer with the purchase of RestoraPet’s AM and PM supplement packages.

As a registered nurse, RestoraPet CEO Brian Larsen, who self-funded RestoraPet while serving as director at Oakview Nursing Home in Maryland, has been providing hand sanitizer to health care facilities in Maryland, Washington, D.C. and Virginia for healthcare workers and the elderly, who have been disproportionately affected by the COVID-19 virus.

“It wasn’t our intention when we began our donations to start making another product full time, but we realized that our production line and manufacturing facility is uniquely set up to easily pivot and produce hand sanitizer in large quantities,” said Larsen. “As the world continues to constantly change, it became increasingly important to us to keep up with the needs of our customers and their entire families – both pets and humans.”

Rejuvien hand sanitizer reflects RestoraPet’s commitment to quality and control by adhering to the exact standards set by the World Health Organization (WHO) and the Centers for Disease Control (CDC). Rejuvien is also available to retailers around the country interested in selling its product.

RestoraPet is a health supplement that restores wellness in older pets experiencing age-related decline and boosts the health and well-being of younger pets. To learn more about RestoraPet, visit http://www.restorapet.com.

###

About RestoraPet

RestoraPet® is the most effective line of pet supplements ever created. Made with the perfect blend of love and science, RestoraPet® restores wellness in older pets experiencing age-related decline and boosts the health and well-being of younger pets. First introduced to the market in 2014, RestoraPet® products are now used by tens of thousands of pets (especially dogs, cats, and horses) in more than 100 countries worldwide. RestoraPet® contains a remarkable, carbon-based “super antioxidant” that scientists created called Vitalitrol®, and begins working from the very first administered dose to rehabilitate and protect almost every type of cell in a pet’s body. Learn more at restorapet.com

Share article on social media or email:

High Grade Hemp Seed Announces International Distribution in Europe


News Image

“Having an established neighbor in a growing European market helps pave an easier path for the hemp farmer,” says Mike Leago, COO of High Grade. “This expansion will encourage European hemp cultivators to try new varietals, better diversify their crops, and increase profitability.“

High Grade Hemp Seed is answering the demand for best-in-class hemp cultivars in Europe with a powerful new distribution partnership, making High Grade’s entire catalog available internationally. This is the first of many steps toward streamlining full international distribution, and opens up the European market in a way that was previously difficult to navigate. It also ensures faster access, facilitating easier processing and rapid shipping timelines within the European Union, as well as providing access to previously difficult to obtain best-in-class hemp genetics.

All High Grade Hemp Seed strains are now available for sale as seeds in Europe.

“Amidst the turmoil in import/export regulations and the ever-changing political landscape, having an established neighbor in a growing European market helps pave an easier path for the hemp farmer,” says Mike Leago, COO of High Grade. “It takes strong relationships built on trust and transparency to create a partnership that is effective across the ocean. We have that faith in Swiss Cannabinoid to stand beside us as we help elevate seed genetics worldwide. This expansion will encourage European hemp cultivators to try new varietals, better diversify their crops, and increase profitability.“

High Grade Hemp Seed and Swiss Cannabinoid launched its official collaboration earlier this year by paving the way in CBG production in the U.S. with the release of its highly popular new strain, Matterhorn CBG. This international distribution agreement builds upon that partnership, making the entire High Grade portfolio of proven hemp genetics available to European buyers.

Matthias Ghidossi, founder of Swiss Cannabinoid, has been a key player in the European hemp industry for years. Of the High Grade partnership, Ghidossi shared, “After kick-starting a highly synergistic relationship with the High Grade team on Matterhorn, becoming their European distribution partners was a natural progression. As one of the largest and most respected hemp genetics companies in the world, this fresh infusion of hemp cultivars into the European market will be a great benefit to farmers across the EU.”

Isaac Cohen, Chief Financial Officer at High Grade Hemp Seed, stated, “Our team has successfully navigated regulatory hurdles, distribution and fulfillment complexity, and customer service considerations to build a robust distribution ecosystem capable of selling and shipping our hemp cultivars to farmers throughout Europe. This has been a huge endeavor, and I’m immensely proud of our team for getting the job done in time for 2020 planting.”

Looking ahead to 2021 and beyond, High Grade is pushing R&D with 20 new terpene crosses and leading edge genetics focused on high-potential minor cannabinoids. The company’s mission continues to center on the needs of farmers, delivering the best genetics and superior results to power their success.

For the full list and background on High Grade’s best-in-class varietals, visit HighGradeHempSeed.com . For Europe orders, visit https://swisscannabinoid.ch/.

About High Grade Hemp Seed

HGH Seed, Inc., is a Colorado-based hemp genetics company committed to farming top-quality, consistent strains of hemp. High Grade has been pivotal in the reintroduction of industrial hemp to the global supply chain. CEO Bodhi Urban and the High Grade team introduced foundational strains such as Cherry Wine and Berry Blossom that are the basis of hemp genetics today. The company is known for its proven track record of compliance, high feminization and germination rates, and high cannabinoid levels. To learn more about High Grade, or to inquire about purchasing seeds, visit highgradehempseed.com.

About Swiss Cannabinoid

Swiss Cannabinoid is a pioneering company focused on research and development for new genetics of Cannabis Sativa l. In the past several years, the company has been pivotal in the development of new strain lines with low THC content. Today Swiss Cannabinoid collaborates with pharmaceutical companies and key players in the cannabis industry, ranging from North America to Eastern Europe. They are also extending their role across the supply chain and are a key distributor for High Grade in Europe. To learn more, visit swisscannabinoid.ch.

Share article on social media or email: